RAYMOND JAMES & ASSOCIATES - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 37 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$73,000
-34.2%
117,918
+3.2%
0.00%
Q1 2019$111,000
+33.7%
114,241
+8.5%
0.00%
Q4 2018$83,000
-39.4%
105,243
-0.0%
0.00%
Q3 2018$137,000
+3.0%
105,293
-3.7%
0.00%
Q2 2018$133,000
-10.7%
109,293
+0.5%
0.00%
Q1 2018$149,000
+2.8%
108,793
+3.8%
0.00%
Q4 2017$145,000
+7.4%
104,793
+17.2%
0.00%
Q3 2017$135,000
+513.6%
89,443
+427.9%
0.00%
Q2 2017$22,000
+57.1%
16,943
+45.5%
0.00%
Q1 2017$14,000
-22.2%
11,643
-8.6%
0.00%
Q4 2016$18,000
-18.2%
12,743
-7.3%
0.00%
Q3 2016$22,000
+22.2%
13,7430.0%0.00%
Q2 2016$18,000
-14.3%
13,743
+3.8%
0.00%
Q1 2016$21,00013,2430.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ARK Investment Management 3,793,249$3,679,0000.10%
Nikko Asset Management Americas, Inc. 928,240$900,0000.02%
ETF MANAGERS GROUP, LLC 243,009$233,0000.01%
Virtu Financial LLC 85,104$83,0000.01%
Psagot Value Holdings Ltd. 127,215$123,0000.01%
HERITAGE INVESTORS MANAGEMENT CORP 74,878$73,0000.00%
Harel Insurance Investments & Financial Services Ltd. 33,794$33,0000.00%
Certified Advisory Corp 5,000$5,0000.00%
Sumitomo Mitsui Trust Holdings, Inc. 908,095$881,0000.00%
Renaissance Technologies 1,580,610$1,533,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders